El Salvador vs Suriname: Cause of death, by non-communicable diseases, female
El Salvador
60.5%
in 2021
Suriname
60.5%
in 2021
El Salvador rank
123rd
Suriname rank
122nd
Cause of death, by non-communicable diseases, female over time
- El Salvador
- Suriname
How they compare
Suriname currently reports 60.5% against 60.5% in El Salvador, a difference of 0.0%.
Across all 6 years both countries report, Suriname has been ahead every year.
El Salvador ranks 123rd and Suriname ranks 122nd of 185 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.7% | 65.1% | 4.4% | Suriname |
| 2010s | 74.5% | 78.3% | 3.8% | Suriname |
| 2020s | 61.8% | 69.8% | 8.0% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, El Salvador or Suriname?
- Suriname, at 60.5% against 60.5% in El Salvador as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between El Salvador and Suriname?
- 0.0%, with Suriname ahead.
- How many years of comparable data are there for El Salvador and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do El Salvador and Suriname rank globally for cause of death, by non-communicable diseases, female?
- El Salvador ranks 123rd and Suriname ranks 122nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.